These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22160377)

  • 1. EGFL7: a unique angiogenic signaling factor in vascular development and disease.
    Nichol D; Stuhlmann H
    Blood; 2012 Feb; 119(6):1345-52. PubMed ID: 22160377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7.
    Nichol D; Shawber C; Fitch MJ; Bambino K; Sharma A; Kitajewski J; Stuhlmann H
    Blood; 2010 Dec; 116(26):6133-43. PubMed ID: 20947685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFL7 ligates αvβ3 integrin to enhance vessel formation.
    Nikolic I; Stankovic ND; Bicker F; Meister J; Braun H; Awwad K; Baumgart J; Simon K; Thal SC; Patra C; Harter PN; Plate KH; Engel FB; Dimmeler S; Eble JA; Mittelbronn M; Schäfer MK; Jungblut B; Chavakis E; Fleming I; Schmidt MHH
    Blood; 2013 Apr; 121(15):3041-50. PubMed ID: 23386126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of EGFL7 in human cancers: A review.
    de Oliveira C; Gonçalves PG; Bidinotto LT
    J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egfl7 is differentially expressed in arteries and veins during retinal vascular development.
    Poissonnier L; Villain G; Soncin F; Mattot V
    PLoS One; 2014; 9(3):e90455. PubMed ID: 24595089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
    Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
    Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal.
    Schmidt MHH; Bicker F; Nikolic I; Meister J; Babuke T; Picuric S; Müller-Esterl W; Plate KH; Dikic I
    Nat Cell Biol; 2009 Jul; 11(7):873-80. PubMed ID: 19503073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway.
    Charpentier MS; Christine KS; Amin NM; Dorr KM; Kushner EJ; Bautch VL; Taylor JM; Conlon FL
    Dev Cell; 2013 Apr; 25(2):132-43. PubMed ID: 23639441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury.
    Campagnolo L; Leahy A; Chitnis S; Koschnick S; Fitch MJ; Fallon JT; Loskutoff D; Taubman MB; Stuhlmann H
    Am J Pathol; 2005 Jul; 167(1):275-84. PubMed ID: 15972971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.
    Usuba R; Pauty J; Soncin F; Matsunaga YT
    Biomaterials; 2019 Mar; 197():305-316. PubMed ID: 30684886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
    Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor-like domain 7 is a novel inhibitor of neutrophil adhesion to coronary artery endothelial cells injured by calcineurin inhibition.
    Badiwala MV; Guha D; Tumiati L; Joseph J; Ghashghai A; Ross HJ; Delgado DH; Rao V
    Circulation; 2011 Sep; 124(11 Suppl):S197-203. PubMed ID: 21911813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAGP-1 and fibronectin control EGFL7 functions by driving its deposition into distinct endothelial extracellular matrix locations.
    Villain G; Lelievre E; Broekelmann T; Gayet O; Havet C; Werkmeister E; Mecham R; Dusetti N; Soncin F; Mattot V
    FEBS J; 2018 Dec; 285(23):4394-4412. PubMed ID: 30338930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis.
    Veikkola T; Alitalo K
    Dev Cell; 2002 Sep; 3(3):302-4. PubMed ID: 12361591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells.
    Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G
    Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
    Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia.
    Bill M; Pathmanathan A; Karunasiri M; Shen C; Burke MH; Ranganathan P; Papaioannou D; Zitzer NC; Snyder K; LaRocco A; Walker AE; Brannan ZJ; Nalin AP; Freud AG; Dikov MM; Zhang X; Bloomfield CD; Garzon R; Dorrance AM
    Clin Cancer Res; 2020 Feb; 26(3):669-678. PubMed ID: 31672772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFL7 enhances surface expression of integrin α
    Dudvarski Stanković N; Bicker F; Keller S; Jones DT; Harter PN; Kienzle A; Gillmann C; Arnold P; Golebiewska A; Keunen O; Giese A; von Deimling A; Bäuerle T; Niclou SP; Mittelbronn M; Ye W; Pfister SM; Schmidt MHH
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30065025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.